General Electric (GE) recently submitted a confidential initial product offering (IPO) listing for its health care business, seeking to transition it to a publicly traded company. According to reports, GE is currently working with Goldman Sachs, Bank of America, Citigroup, JPMorgan Chase, and Morgan Stanley to achieve the move.
If successful, GE Healthcare would experience quicker and more efficient operations, bolstering its ability to respond to industry changes. Should the IPO filing see fruition, current GE Healthcare CEO Kieran Murphy would remain at the helm of the organization. Additionally, it is anticipated that the move would see GE Healthcare investing more into artificial intelligence, connected devices, and smart diagnostics.
GE Healthcare Inc. provides medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. GE Healthcare operates as the health care business of General Electric.
This was reported by Fierce Biotech on December 19, 2018.
Contact Information: GE Healthcare Inc., 100 Results Way, Marlborough, Massachusetts 01752; (508) 475-2000; Website: www.gehealthcare.com